Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Levorphanol tartrate
Drug ID BADD_D01283
Description A narcotic analgesic that may be habit-forming. It is nearly as effective orally as by injection.
Indications and Usage For the management of moderate to severe pain or as a preoperative medication where an opioid analgesic is appropriate.
Marketing Status approved
ATC Code Not Available
DrugBank ID DB00854
KEGG ID D00841
MeSH ID D007981
PubChem ID 5462348
TTD Drug ID D0T3HY
NDC Product Code 0406-0545; 69543-417; 50683-0514; 42358-102; 63629-2093; 0054-0438; 0527-3237; 58159-061; 69543-412; 57664-762; 0527-3236; 0406-2224; 61960-0250
UNII 04WQU6T9QI
Synonyms Levorphanol | Levodroman | Levorphan | Levorphanol Tartrate | Tartrate, Levorphanol | Levo-Dromoran | Levo Dromoran | LevoDromoran | 3-Hydroxy-N-methylmorphinan | 3 Hydroxy N methylmorphinan | L-Dromoran | L Dromoran
Chemical Information
Molecular Formula C21H33NO9
CAS Registry Number 5985-38-6
SMILES CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)O.C(C(C(=O)O)O)(C(=O)O)O.O.O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Abnormal dreams19.02.03.001; 17.15.02.001--Not Available
Amnesia19.20.01.001; 17.03.02.001--
Apnoea22.02.01.001--
Arrhythmia02.03.02.001--Not Available
Biliary colic09.02.01.001--Not Available
Bradycardia02.03.02.002--Not Available
Cardiac arrest02.03.04.001--
Coma17.02.09.001--Not Available
Confusional state19.13.01.001; 17.02.03.005--
Constipation07.02.02.001--
Cyanosis22.02.02.007; 23.06.04.005; 02.11.04.004; 24.03.01.007--
Depression19.15.01.001--
Diplopia17.17.01.005; 06.02.06.002--Not Available
Dizziness24.06.02.007; 17.02.05.003; 02.11.04.006--
Drug withdrawal syndrome19.07.06.013; 08.06.02.004--Not Available
Dry mouth07.06.01.002--
Dyskinesia17.01.02.006--
Dyspepsia07.01.02.001--
Dysuria20.02.02.002--
Extrasystoles02.03.02.003--Not Available
Flushing23.06.05.003; 08.01.03.025; 24.03.01.002--
Hyperhidrosis23.02.03.004; 08.01.03.028--
Hyperkinesia17.01.02.008--Not Available
Hypokinesia17.01.02.009--Not Available
Hypotension24.06.03.002--
Hypoventilation22.02.01.007--Not Available
Injection site reaction08.02.03.014; 12.07.03.015--
Insomnia19.02.01.002; 17.15.03.002--
Lethargy19.04.04.004; 17.02.04.003; 08.01.01.008--
The 1th Page    1 2    Next   Last    Total 2 Pages